The ALK Story: Rapid Bench-to-Bedside Journey Helps Set New Pace for Cancer Drugs

Alice T. Shaw, MD, PhD, and D. Ross Camidge, MD, PhD, discuss the evolution of ALK-targeting therapies, the impact on the drug development paradigm, and the prospects for future advancements.

More From BioPortfolio on "The ALK Story: Rapid Bench-to-Bedside Journey Helps Set New Pace for Cancer Drugs"